HONOLULU — In patients with Barrett's esophagus, low-grade dysplasia carries a substantial risk for progression to esophageal adenocarcinoma, investigators report. The risk for progression in patients ...
By integrating data across multiple studies, this analysis confirms that TissueCypher provides consistent, reproducible ...
“A diagnosis of low-grade dysplasia in Barrett’s esophagus warrants expert pathology review, as these patients may have a significant risk of developing esophageal cancer. However, expert pathology ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a new study published in The ...
Please provide your email address to receive an email when new articles are posted on . Researchers identified bile duct dysplasia or cholangiocarcinoma in 71% of explanted livers in the indication of ...
A phase Ib/II study of fruquintinib in combination with SOX and toripalimab as first-line treatment for advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC). Infusional ...
Credit: Getty Images A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis. A 29-year-old White man presents in May 2023 ...
Do bisphosphonates increase esophageal cancer risk? A meta-analysis. Background: Endoscopic submucosal dissection (ESD) is used for the treatment of gastric adenoma as well as early gastric cancer.
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback